A sizable retrospective study involving the University of Buffalo, Aetion, Inc., HealthVerity, Inc. and the University of Toronto confirms a significant number of complications associated with COVID-19. Published in the Canadian Medical Association Journal (CMAJ),...
University of Buffalo
Category
Patient Genotyping May Turn Failed Alzheimer’s Drugs Into Successful Ones
On October 6, UBMD Medical Group published “Patient Genotyping: Potential Key to Treating Alzheimer’s,” arguing that prior trials that found no benefit for Alzheimer’s medicines need to be re-examined in light of new discoveries in genotyping and a recent...
University of Buffalo Prepares Melatonin Trial Targeting Mild to Moderate COVID-19
Could the natural sleep aid melatonin serve as a treatment for patients with mild and moderate COVID-19? Apparently, researchers at the University at Buffalo seek to find out, and the university Institutional Review Board granted approval to proceed. The U.S. Food and...
UB Ramps Up Research in a New COVID-19 Reality
The University of Buffalo (UB) paused most research (other than COVID-19 studies) by March 23 due to the COVID-19 pandemic. Nearly four months later, a “research ramp-up” is underway where investigators and staff are enthusiastic about commencing the critical research...
University of Buffalo Leads Telehealth-enabled Decentralized Study Investigating if Asthma Treatment can Ease COVID-19
Researchers from the Department of Emergency Medicine at the University of Buffalo Jacobs School of Medicine and Biomedical Sciences initiated a clinical trial evaluating whether a steroid medication typically used to treat asthma can help ill patients at home. A...
UB School of Pharmacy Investigators Awarded Over $10m & Full Throttle on Critical & Timely Studies
A research team from the University of Buffalo School of Pharmacy and Pharmaceutical Sciences have received $10 million to commence four studies, including 1) examine the effects of drug toxicity on cognitive disorders in older adults with HIV; 2) develop urgent...
University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm
University of Buffalo (UB) and Roswell Park Comprehensive Cancer Center received the greenlight from the U.S. Food and Drug Administration to initial a “collaborative clinical study” using sarilumab to address some adverse COVID-19 effects. The study’s principal...
University of Buffalo Investigators Contribute to the Global Trial Leading to the Approval of Fiasp®
Two clinical investigators from the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo (UB) participated in a successful worldwide Novo Nordisk-sponsored clinical trial, confirming that a fast-acting insulin is safe for children with...
UB Translational Consortium Receives $21.7m & Drives Innovative Community-Focused Translational Research Targeting SDoH
The University of Buffalo (UB) Buffalo Translational Consortium has received nearly $22 million in grant money from the National Institutes of Health. UB’s translational consortium, a regional hub of innovative biomedical research, now receives funding to help it...
UB Investigator Secures $2m ‘MIRA’ Grant for Enzyme & Cancer Research
The National Institutes of Health has granted $2 million to UB Chemistry professor John Richard, an expert in enzymes research. The five-year grant will help Dr. Richard pursue his research centering on the importance of enzymes to cancer. Dr. Richard is on a mission...
UB, UCSF & UNC Make Melatonin Discovery to Someday Fix Biological Clocks
A collaborative research team including members from University of California, San Francisco (UCSF), the University of North Carolina at Chapel Hill (UNC), and University of Buffalo (UB) have utilized a vast and novel computational library the first molecules that can...
UB Receives $21.7m CTSA Awards Contributing to Dynamic Regional Clinical Research Model
University of Buffalo (UB) has been awarded a five-year, $21.7 million Clinical Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences of National Institutes of Health (NIH) in recognition of the dramatic progress the...
Western New York Clinical Research Boom
Western New York has emerged as a sizeable regional powerhouse for medical and clinical research as millions of dollars of federal funding flow into investigations into new medicines and devices to treat chronic and deadly disease. From the University of Buffalo and...
University of Buffalo Launches Clinical Trials Portal Integrated with Back-end CTMS & Financial Systems
University of Buffalo (UB) is on the move when it comes to clinical trials. What has been an incredibly fragmented and incomplete process, frustrating investigators and prospective study participants, becomes more integrated and seamless as the UB Clinical...
University of Buffalo Spin-off Venture Raises $1m & Develops Aneurysm Detection Test
A University at Buffalo-based research team is conducting research to assess a blood test that could screen brains for aneurysms. Their spin-off company has secured $1 million to develop the technology. A Deadly Condition Americans experience aneurysms approximately...
UB’s Empire Discovery Institute Funding & Supporting Early Stage Clinical Investigators
The Empire Discovery Institute (EDI), a drug discovery and development accelerator in Upstate New York, invites University of Buffalo (UB) researchers and investigators interested in developing pharmaceuticals to apply for project funding and support. Established by...
University of Buffalo Launches Biobank in Downtown Research Center
The University at Buffalo has opened up a biobank facility in the downtown Clinical and Translational Research Center. The new center will house a state-of-the-art biobank where biological samples are collected, processed, and stored, as well as utilized for a range...
University of Buffalo Launches Personalized Pharmacotherapy Master’s Degree Program
University of Buffalo School of Pharmacy and Pharmaceutical Sciences now offers an innovative master’s degree program in pharmacometrics and personalized pharmacotherapy. With advances in the fast-paced personalized medicine field, there is an urgent need for highly...
University of Buffalo Chair of AHA Writing Group: Pediatric Heart & Muscle Disease Research Urgent
According to the University of Buffalo Chair of AHA writing group, though rare, heart muscle disease causes some of the world disease in children, reports Ellen Goldbaum of University of Buffalo News. What is this disease? Cardiomyopathy, a heart condition involving...
University of Buffalo & Circuit Clinical Harness Regional Assets In Effort to Build Clinical Trial Hub
Why do many clinical trials fail? Do researchers struggle to find participants? Do participants feel they will be treated like “guinea pigs”? Are the regulatory and legal hurdles are too much? How about all of the above. Medical research is burdened with widespread...